nodes	percent_of_prediction	percent_of_DWPC	metapath
Ardeparin—Aspartate aminotransferase increased—Sunitinib—pancreatic cancer	0.00466	0.00466	CcSEcCtD
Ardeparin—Pneumonia—Erlotinib—pancreatic cancer	0.00463	0.00463	CcSEcCtD
Ardeparin—Local reaction—Doxorubicin—pancreatic cancer	0.00457	0.00457	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Sunitinib—pancreatic cancer	0.00456	0.00456	CcSEcCtD
Ardeparin—Myocardial infarction—Tamoxifen—pancreatic cancer	0.00456	0.00456	CcSEcCtD
Ardeparin—Vesiculobullous rash—Doxorubicin—pancreatic cancer	0.00452	0.00452	CcSEcCtD
Ardeparin—Myocardial infarction—Erlotinib—pancreatic cancer	0.00451	0.00451	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.0044	0.0044	CcSEcCtD
Ardeparin—Thrombocytosis—Epirubicin—pancreatic cancer	0.0044	0.0044	CcSEcCtD
Ardeparin—Dermatitis bullous—Gemcitabine—pancreatic cancer	0.00434	0.00434	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.00429	0.00429	CcSEcCtD
Ardeparin—Dermatitis bullous—Fluorouracil—pancreatic cancer	0.00427	0.00427	CcSEcCtD
Ardeparin—Cardiac failure—Gemcitabine—pancreatic cancer	0.00425	0.00425	CcSEcCtD
Ardeparin—Haemoglobin—Tamoxifen—pancreatic cancer	0.0042	0.0042	CcSEcCtD
Ardeparin—Inflammation—Docetaxel—pancreatic cancer	0.00418	0.00418	CcSEcCtD
Ardeparin—Cardiac failure—Fluorouracil—pancreatic cancer	0.00418	0.00418	CcSEcCtD
Ardeparin—Haemorrhage—Tamoxifen—pancreatic cancer	0.00418	0.00418	CcSEcCtD
Ardeparin—Haemoglobin—Erlotinib—pancreatic cancer	0.00416	0.00416	CcSEcCtD
Ardeparin—Haemorrhage—Erlotinib—pancreatic cancer	0.00413	0.00413	CcSEcCtD
Ardeparin—Oedema peripheral—Tamoxifen—pancreatic cancer	0.00412	0.00412	CcSEcCtD
Ardeparin—Thrombocytosis—Doxorubicin—pancreatic cancer	0.00407	0.00407	CcSEcCtD
Ardeparin—Hepatocellular injury—Docetaxel—pancreatic cancer	0.00406	0.00406	CcSEcCtD
Ardeparin—Pneumonia—Sunitinib—pancreatic cancer	0.00401	0.00401	CcSEcCtD
Ardeparin—Paralysis—Epirubicin—pancreatic cancer	0.00394	0.00394	CcSEcCtD
Ardeparin—Skin exfoliation—Docetaxel—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Ardeparin—Thrombosis—Epirubicin—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Irinotecan—pancreatic cancer	0.00384	0.00384	CcSEcCtD
Ardeparin—Hyperlipidaemia—Epirubicin—pancreatic cancer	0.0038	0.0038	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Gemcitabine—pancreatic cancer	0.00374	0.00374	CcSEcCtD
Ardeparin—Dermatitis atopic—Epirubicin—pancreatic cancer	0.0037	0.0037	CcSEcCtD
Ardeparin—Alopecia—Tamoxifen—pancreatic cancer	0.00369	0.00369	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Gemcitabine—pancreatic cancer	0.00366	0.00366	CcSEcCtD
Ardeparin—Alopecia—Erlotinib—pancreatic cancer	0.00365	0.00365	CcSEcCtD
Ardeparin—Paralysis—Doxorubicin—pancreatic cancer	0.00365	0.00365	CcSEcCtD
Ardeparin—Erythema—Tamoxifen—pancreatic cancer	0.00364	0.00364	CcSEcCtD
Ardeparin—Pulmonary oedema—Docetaxel—pancreatic cancer	0.00361	0.00361	CcSEcCtD
Ardeparin—Erythema—Erlotinib—pancreatic cancer	0.0036	0.0036	CcSEcCtD
Ardeparin—Haemoglobin—Sunitinib—pancreatic cancer	0.0036	0.0036	CcSEcCtD
Ardeparin—Haemorrhage—Sunitinib—pancreatic cancer	0.00358	0.00358	CcSEcCtD
Ardeparin—Thrombosis—Doxorubicin—pancreatic cancer	0.00358	0.00358	CcSEcCtD
Ardeparin—Oedema peripheral—Sunitinib—pancreatic cancer	0.00353	0.00353	CcSEcCtD
Ardeparin—Hyperlipidaemia—Doxorubicin—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Ardeparin—Eosinophilia—Fluorouracil—pancreatic cancer	0.00349	0.00349	CcSEcCtD
Ardeparin—Rash pustular—Epirubicin—pancreatic cancer	0.00343	0.00343	CcSEcCtD
Ardeparin—Dermatitis atopic—Doxorubicin—pancreatic cancer	0.00342	0.00342	CcSEcCtD
Ardeparin—Anaemia—Tamoxifen—pancreatic cancer	0.00336	0.00336	CcSEcCtD
Ardeparin—Injection site pain—Epirubicin—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Ardeparin—Pneumonia—Irinotecan—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Ardeparin—Myocardial infarction—Irinotecan—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Ardeparin—Pneumonia—Gemcitabine—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Ardeparin—Rash pustular—Doxorubicin—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Ardeparin—Pneumonia—Fluorouracil—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Ardeparin—Alopecia—Sunitinib—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Ardeparin—Myocardial infarction—Gemcitabine—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Ardeparin—Erythema—Sunitinib—pancreatic cancer	0.00312	0.00312	CcSEcCtD
Ardeparin—Atrial fibrillation—Docetaxel—pancreatic cancer	0.00311	0.00311	CcSEcCtD
Ardeparin—Injection site pain—Doxorubicin—pancreatic cancer	0.0031	0.0031	CcSEcCtD
Ardeparin—Myocardial infarction—Fluorouracil—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Ardeparin—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Ardeparin—Haematuria—Gemcitabine—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Ardeparin—Cardiac failure—Docetaxel—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Ardeparin—Oedema—Tamoxifen—pancreatic cancer	0.00297	0.00297	CcSEcCtD
Ardeparin—Haemoglobin—Irinotecan—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Ardeparin—Haemorrhage—Irinotecan—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Ardeparin—Oedema—Erlotinib—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Ardeparin—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00291	0.00291	CcSEcCtD
Ardeparin—Shock—Erlotinib—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Ardeparin—Haemoglobin—Gemcitabine—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Ardeparin—Anaemia—Sunitinib—pancreatic cancer	0.00288	0.00288	CcSEcCtD
Ardeparin—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00288	0.00288	CcSEcCtD
Ardeparin—Haemorrhage—Gemcitabine—pancreatic cancer	0.00287	0.00287	CcSEcCtD
Ardeparin—Haemoglobin—Fluorouracil—pancreatic cancer	0.00284	0.00284	CcSEcCtD
Ardeparin—Oedema peripheral—Gemcitabine—pancreatic cancer	0.00283	0.00283	CcSEcCtD
Ardeparin—Haemorrhage—Fluorouracil—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Ardeparin—Inflammation—Epirubicin—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Ardeparin—Hepatocellular injury—Epirubicin—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Ardeparin—Hyperkalaemia—Epirubicin—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Ardeparin—Dyspnoea—Tamoxifen—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Ardeparin—Dyspnoea—Erlotinib—pancreatic cancer	0.00262	0.00262	CcSEcCtD
Ardeparin—Skin exfoliation—Epirubicin—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Ardeparin—Inflammation—Doxorubicin—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Ardeparin—Alopecia—Irinotecan—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Ardeparin—Oedema—Sunitinib—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Ardeparin—Pain—Tamoxifen—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Ardeparin—Alopecia—Gemcitabine—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Ardeparin—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.00253	0.00253	CcSEcCtD
Ardeparin—Pain—Erlotinib—pancreatic cancer	0.00251	0.00251	CcSEcCtD
Ardeparin—Shock—Sunitinib—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Ardeparin—Erythema—Gemcitabine—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Ardeparin—Alopecia—Fluorouracil—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Ardeparin—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Ardeparin—Hyperkalaemia—Doxorubicin—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Ardeparin—Ecchymosis—Epirubicin—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Ardeparin—Erythema—Fluorouracil—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Ardeparin—Pulmonary oedema—Epirubicin—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Ardeparin—Skin exfoliation—Doxorubicin—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Ardeparin—Anaemia—Irinotecan—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Ardeparin—Urticaria—Tamoxifen—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Ardeparin—Body temperature increased—Erlotinib—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Ardeparin—Malaise—Irinotecan—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Ardeparin—Anaemia—Gemcitabine—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Ardeparin—Ecchymosis—Doxorubicin—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Ardeparin—Diabetes mellitus—Epirubicin—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Ardeparin—Pneumonia—Docetaxel—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Ardeparin—Anaemia—Fluorouracil—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Ardeparin—Dyspnoea—Sunitinib—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Ardeparin—Malaise—Gemcitabine—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Ardeparin—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Ardeparin—Myocardial infarction—Docetaxel—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Ardeparin—Vascular purpura—Epirubicin—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Ardeparin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Ardeparin—Pain—Sunitinib—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Ardeparin—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Ardeparin—Confusional state—Irinotecan—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Ardeparin—Pruritus—Tamoxifen—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Ardeparin—Oedema—Irinotecan—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Ardeparin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Ardeparin—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Ardeparin—Pruritus—Erlotinib—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Ardeparin—Purpura—Epirubicin—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Ardeparin—Shock—Irinotecan—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Ardeparin—Vascular purpura—Doxorubicin—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Ardeparin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Ardeparin—Haemoglobin—Docetaxel—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Ardeparin—Oedema—Gemcitabine—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Ardeparin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Ardeparin—Haemorrhage—Docetaxel—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Ardeparin—Cardiac failure—Epirubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Ardeparin—Diarrhoea—Tamoxifen—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Ardeparin—Confusional state—Fluorouracil—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Ardeparin—Body temperature increased—Sunitinib—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Ardeparin—Diarrhoea—Erlotinib—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Ardeparin—Oedema peripheral—Docetaxel—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Ardeparin—Oedema—Fluorouracil—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Ardeparin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Ardeparin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.002	0.002	CcSEcCtD
Ardeparin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Ardeparin—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Ardeparin—Purpura—Doxorubicin—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Ardeparin—Cardiac failure—Doxorubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Ardeparin—Hypersensitivity—Sunitinib—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Ardeparin—Dyspnoea—Irinotecan—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Ardeparin—Headache—Tamoxifen—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Ardeparin—Headache—Erlotinib—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Ardeparin—Dyspnoea—Gemcitabine—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Ardeparin—Alopecia—Docetaxel—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Ardeparin—Pruritus—Sunitinib—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Ardeparin—Pain—Irinotecan—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Ardeparin—Dyspnoea—Fluorouracil—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Ardeparin—Erythema—Docetaxel—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Ardeparin—Nausea—Tamoxifen—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Ardeparin—Pain—Gemcitabine—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Ardeparin—Nausea—Erlotinib—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Ardeparin—Diarrhoea—Sunitinib—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Ardeparin—Feeling abnormal—Irinotecan—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Ardeparin—Pain—Fluorouracil—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Ardeparin—Eosinophilia—Epirubicin—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Ardeparin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Ardeparin—Body temperature increased—Irinotecan—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Ardeparin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Ardeparin—Anaemia—Docetaxel—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Ardeparin—Body temperature increased—Gemcitabine—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Ardeparin—Urticaria—Fluorouracil—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Ardeparin—Headache—Sunitinib—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Ardeparin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Ardeparin—Eosinophilia—Doxorubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Ardeparin—Hypersensitivity—Irinotecan—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Ardeparin—Pneumonia—Epirubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Ardeparin—Nausea—Sunitinib—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Ardeparin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Ardeparin—Haematuria—Epirubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Ardeparin—Confusional state—Docetaxel—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Ardeparin—Oedema—Docetaxel—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Ardeparin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Ardeparin—Pruritus—Gemcitabine—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Ardeparin—Diarrhoea—Irinotecan—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Ardeparin—Pneumonia—Doxorubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Ardeparin—Shock—Docetaxel—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Ardeparin—Pruritus—Fluorouracil—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Ardeparin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Ardeparin—Diarrhoea—Gemcitabine—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Ardeparin—Haemoglobin—Epirubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Ardeparin—Haemorrhage—Epirubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Ardeparin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Ardeparin—Oedema peripheral—Epirubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Ardeparin—Haematuria—Doxorubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Ardeparin—Headache—Irinotecan—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Ardeparin—Dyspnoea—Docetaxel—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Ardeparin—Haemoglobin—Doxorubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Ardeparin—Headache—Gemcitabine—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Ardeparin—Haemorrhage—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Ardeparin—Headache—Fluorouracil—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Ardeparin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Ardeparin—Nausea—Irinotecan—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Ardeparin—Pain—Docetaxel—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Ardeparin—Alopecia—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Ardeparin—Nausea—Gemcitabine—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Ardeparin—Erythema—Epirubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Ardeparin—Feeling abnormal—Docetaxel—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Ardeparin—Nausea—Fluorouracil—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Ardeparin—Body temperature increased—Docetaxel—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Ardeparin—Alopecia—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Ardeparin—Erythema—Doxorubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Ardeparin—Anaemia—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Ardeparin—Malaise—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Ardeparin—Hypersensitivity—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Ardeparin—Pruritus—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Ardeparin—Anaemia—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Ardeparin—Malaise—Doxorubicin—pancreatic cancer	0.000998	0.000998	CcSEcCtD
Ardeparin—Diarrhoea—Docetaxel—pancreatic cancer	0.000991	0.000991	CcSEcCtD
Ardeparin—Confusional state—Epirubicin—pancreatic cancer	0.000985	0.000985	CcSEcCtD
Ardeparin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000977	0.000977	CcSEcCtD
Ardeparin—Oedema—Epirubicin—pancreatic cancer	0.000977	0.000977	CcSEcCtD
Ardeparin—Shock—Epirubicin—pancreatic cancer	0.000961	0.000961	CcSEcCtD
Ardeparin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000956	0.000956	CcSEcCtD
Ardeparin—Confusional state—Doxorubicin—pancreatic cancer	0.000911	0.000911	CcSEcCtD
Ardeparin—Headache—Docetaxel—pancreatic cancer	0.000907	0.000907	CcSEcCtD
Ardeparin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000904	0.000904	CcSEcCtD
Ardeparin—Oedema—Doxorubicin—pancreatic cancer	0.000904	0.000904	CcSEcCtD
Ardeparin—Shock—Doxorubicin—pancreatic cancer	0.000889	0.000889	CcSEcCtD
Ardeparin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000885	0.000885	CcSEcCtD
Ardeparin—Dyspnoea—Epirubicin—pancreatic cancer	0.000871	0.000871	CcSEcCtD
Ardeparin—Nausea—Docetaxel—pancreatic cancer	0.00086	0.00086	CcSEcCtD
Ardeparin—Pain—Epirubicin—pancreatic cancer	0.000835	0.000835	CcSEcCtD
Ardeparin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000806	0.000806	CcSEcCtD
Ardeparin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000805	0.000805	CcSEcCtD
Ardeparin—Urticaria—Epirubicin—pancreatic cancer	0.000776	0.000776	CcSEcCtD
Ardeparin—Pain—Doxorubicin—pancreatic cancer	0.000773	0.000773	CcSEcCtD
Ardeparin—Body temperature increased—Epirubicin—pancreatic cancer	0.000772	0.000772	CcSEcCtD
Ardeparin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000745	0.000745	CcSEcCtD
Ardeparin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000719	0.000719	CcSEcCtD
Ardeparin—Urticaria—Doxorubicin—pancreatic cancer	0.000718	0.000718	CcSEcCtD
Ardeparin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000714	0.000714	CcSEcCtD
Ardeparin—Pruritus—Epirubicin—pancreatic cancer	0.000691	0.000691	CcSEcCtD
Ardeparin—Diarrhoea—Epirubicin—pancreatic cancer	0.000668	0.000668	CcSEcCtD
Ardeparin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000666	0.000666	CcSEcCtD
Ardeparin—Pruritus—Doxorubicin—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Ardeparin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000618	0.000618	CcSEcCtD
Ardeparin—Headache—Epirubicin—pancreatic cancer	0.000612	0.000612	CcSEcCtD
Ardeparin—Nausea—Epirubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Ardeparin—Headache—Doxorubicin—pancreatic cancer	0.000566	0.000566	CcSEcCtD
Ardeparin—Nausea—Doxorubicin—pancreatic cancer	0.000537	0.000537	CcSEcCtD
